Cargando…

Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran

Breast cancer is the first of the most important causes of the deaths of women in the world and in Iran. There are various causes and causes of this cancer, one of which has recently been described as a cause of breast cancer, is the human papillomavirus (HPV). The HPV is transmitted through sexual...

Descripción completa

Detalles Bibliográficos
Autores principales: Afshar, Reza Malekpour, Balar, Negin, Mollaei, Hamid Reza, Arabzadeh, Seyed Alimohammad, Iranpour, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318420/
https://www.ncbi.nlm.nih.gov/pubmed/30485938
http://dx.doi.org/10.31557/APJCP.2018.19.11.3039
_version_ 1783384873472360448
author Afshar, Reza Malekpour
Balar, Negin
Mollaei, Hamid Reza
Arabzadeh, Seyed Alimohammad
Iranpour, Maryam
author_facet Afshar, Reza Malekpour
Balar, Negin
Mollaei, Hamid Reza
Arabzadeh, Seyed Alimohammad
Iranpour, Maryam
author_sort Afshar, Reza Malekpour
collection PubMed
description Breast cancer is the first of the most important causes of the deaths of women in the world and in Iran. There are various causes and causes of this cancer, one of which has recently been described as a cause of breast cancer, is the human papillomavirus (HPV). The HPV is transmitted through sexual contact and skin lesions. There are more than 100 types of HPV that can influence different parts of the body. Some types of HPV can cause cancer (such as cervical or anal cancer) and others can cause warts (such as genital or plantar warts). To study the risk of HPV infection in Breast Cancer, we managed a Case-Control study in Kerman, southeast of Iran. For this purpose, 98 paraffin blocks of breast cancer and 40 paraffin blocks of fibrocystic as a control were tested for the presence of HPV DNA using Real-Time PCR, and HPV typing was done using INNo-Lippa assay. HPV DNA was detected in 8 out of 98 patients (8.2%), while it was not detected in the control group samples. HPV types 16, 18 were the most common (62.5%) types in positive samples. The prevalence of HPV in patients with breast cancer of Iran is very low and less than other regions of the world, it seems that maybe rout of transmission of HPV in Iran is under control. No one knows exactly why breast cancer occurs. The environment, hormones, Viruses, or your lifestyle could all play a role in the development of breast cancer. Currently, Vaccination is the best way to prevent cancer that’s due to HPV. However, additional studies on the larger group of patients are needed to explain the roles of HPV in Breast cancer.
format Online
Article
Text
id pubmed-6318420
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-63184202019-01-14 Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran Afshar, Reza Malekpour Balar, Negin Mollaei, Hamid Reza Arabzadeh, Seyed Alimohammad Iranpour, Maryam Asian Pac J Cancer Prev Research Article Breast cancer is the first of the most important causes of the deaths of women in the world and in Iran. There are various causes and causes of this cancer, one of which has recently been described as a cause of breast cancer, is the human papillomavirus (HPV). The HPV is transmitted through sexual contact and skin lesions. There are more than 100 types of HPV that can influence different parts of the body. Some types of HPV can cause cancer (such as cervical or anal cancer) and others can cause warts (such as genital or plantar warts). To study the risk of HPV infection in Breast Cancer, we managed a Case-Control study in Kerman, southeast of Iran. For this purpose, 98 paraffin blocks of breast cancer and 40 paraffin blocks of fibrocystic as a control were tested for the presence of HPV DNA using Real-Time PCR, and HPV typing was done using INNo-Lippa assay. HPV DNA was detected in 8 out of 98 patients (8.2%), while it was not detected in the control group samples. HPV types 16, 18 were the most common (62.5%) types in positive samples. The prevalence of HPV in patients with breast cancer of Iran is very low and less than other regions of the world, it seems that maybe rout of transmission of HPV in Iran is under control. No one knows exactly why breast cancer occurs. The environment, hormones, Viruses, or your lifestyle could all play a role in the development of breast cancer. Currently, Vaccination is the best way to prevent cancer that’s due to HPV. However, additional studies on the larger group of patients are needed to explain the roles of HPV in Breast cancer. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6318420/ /pubmed/30485938 http://dx.doi.org/10.31557/APJCP.2018.19.11.3039 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Afshar, Reza Malekpour
Balar, Negin
Mollaei, Hamid Reza
Arabzadeh, Seyed Alimohammad
Iranpour, Maryam
Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran
title Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran
title_full Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran
title_fullStr Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran
title_full_unstemmed Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran
title_short Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran
title_sort low prevalence of human papilloma virus in patients with breast cancer, kerman; iran
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318420/
https://www.ncbi.nlm.nih.gov/pubmed/30485938
http://dx.doi.org/10.31557/APJCP.2018.19.11.3039
work_keys_str_mv AT afsharrezamalekpour lowprevalenceofhumanpapillomavirusinpatientswithbreastcancerkermaniran
AT balarnegin lowprevalenceofhumanpapillomavirusinpatientswithbreastcancerkermaniran
AT mollaeihamidreza lowprevalenceofhumanpapillomavirusinpatientswithbreastcancerkermaniran
AT arabzadehseyedalimohammad lowprevalenceofhumanpapillomavirusinpatientswithbreastcancerkermaniran
AT iranpourmaryam lowprevalenceofhumanpapillomavirusinpatientswithbreastcancerkermaniran